Publications for Manfred Hauben manfred.hauben@pfizer.com
Hauben, M., & Hung, E. (2015). Bevacizumab-associated diverticulitis: Results of disproportionality analysis. Expert Review of Clinical Pharmacology, 8(3), 271-272. doi:10.1586/17512433.2015.1041850
Maignen, F., Hauben, M., Hung, E., Holle, L. V., & Dogne, J. M. (2014). A conceptual approach to the masking effect of measures of disproportionality. Pharmacoepidemiology and Drug Safety, 23(2), 208-217. doi:10.1002/pds.3530
Maignen, F., Hauben, M., Hung, E., Van Holle, L., & Dogne, J. M. (2014). Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases. Pharmacoepidemiology and Drug Safety, 23(2), 195-207. doi:10.1002/pds.3529
Hauben, M., & Hung, E. Y. (2013). A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs. Journal of Clinical Pharmacology, 53(7), 762-772. doi:10.1002/jcph.84
Hauben, M., & Hung, E. Y. (2013). Pneumothorax as an adverse drug event: An exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition. International Journal of Medical Sciences, 10(8), 965-973. doi:10.7150/ijms.5377
